Metabolomics in detection of Chemotoxicity

Chemotherapy drugs capable to cause significant, irreversible, life threatening organ damage which is distressing for patients and might affect the optimal delivery of treatment. Various studies have predicted the risk factors for drug induced organ damage because of lack of biomarker to pick-up these changes in early phase causes potential morbidity and mortality. Metabolomics can address relation between gene, drugs environment and thus increase our ability to predict individual variation in drug response phenotypes.

    Related Conference of Metabolomics in detection of Chemotoxicity

    October 21-22, 2020

    18th International Conference on Metabolomics and Proteomics

    Frankfurt, Germany
    December 10-11, 2020

    2nd Pathology and Infectious Disease Conference

    Dubai, UAE
    March 18-19, 2021

    12th Tissue Repair and Regeneration Congress

    Abu Dhabi, UAE
    March 28-29, 2021

    11th Glycobiology World Congress

    Vienna, Austria
    June 11-12, 2021

    25th Global Congress on Biotechnology

    Berlin, Germany
    September 13-14, 2021

    17th World Congress on Structural Biology

    Prague, Czech Republic
    September 27-28, 2021

    25th European Biotechnology Congress

    Dublin, Ireland

    Metabolomics in detection of Chemotoxicity Conference Speakers

    Recommended Sessions

    Related Journals

    Are you interested in